Navigation Links
Gen-Probe Announces Webcast of First Quarter 2011 Earnings Conference Call
Date:4/14/2011

SAN DIEGO, April 14, 2011 /PRNewswire/ -- Gen-Probe Incorporated (NASDAQ: GPRO) announced today that the Company will release its first quarter 2011 financial results on Thursday, April 28, 2011 at approximately 4:00 pm Eastern Time (ET). The announcement will be followed by a conference call with management at 4:30 pm ET.  

The conference call will be webcast live and may be accessed on the investors section of the Company's web site at www.gen-probe.com.  An archived version of the webcast will be available on the same web site for at least 90 days. A telephone replay also will be available for 24 hours after the call ends. To access the replay, please call 800-839-5573 (US) or 402-220-2075 (international).

About Gen-Probe

Gen-Probe is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility.  Gen-Probe has approximately 28 years of expertise in nucleic acid testing (NAT), and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening.  Gen-Probe is headquartered in San Diego and employs approximately 1,400 people. For more information, go to www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements.  Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Gen-Probe Reports Financial Results for the Fourth Quarter and Full Year 2010
2. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2010 Earnings Conference Call
3. Gen-Probe to Webcast Presentation at the 29th Annual J.P. Morgan Healthcare Conference
4. Gen-Probe Acquires GTI Diagnostics for $53 Million in Cash
5. Gen-Probe Announces Webcast of Annual Briefing for Institutional Investors and Financial Analysts
6. Gen-Probe to Acquire Prodesse, Leader in Molecular Testing for Respiratory Infectious Diseases, for $60 Million in Cash Plus Potential Milestone Payments
7. Gen-Probe to Consolidate Industrial Assets Into New, Independent Company
8. Gen-Probe to Webcast Four Upcoming Investor Presentations
9. Gen-Probe to Webcast Two Upcoming Investor Presentations
10. Gen-Probe Completes Acquisition of Tepnel Life Sciences
11. Gen-Probe to Webcast Two Upcoming Investor Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 Today, TiFiber, Inc. ... production facility and future company headquarters in Fort ... new materials that safely and effectively control dangerous ... of its historic, strong support for manufacturing, but ... leading edge, technology-based companies such as TiFiber. ...
(Date:12/19/2014)... Biddeford, ME (PRWEB) December 18, 2014 ... founding director of the Center for Excellence in the ... of New England, has been selected as a member ... He is the first neuroscientist from Maine to receive ... a nonprofit organization supported entirely by the Dana Foundation. ...
(Date:12/19/2014)... (PRWEB) December 18, 2014 iLab Solutions, ... the appointment of Siri Bryant as the new Director ... Director of Core Implementations. These two new leadership positions ... customer service by ensuring that iLab continues to meet ... the last four years, iLab has been deployed at ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 The ... to the rising ageing population and technological innovations ... and nutraceutical industries are catalysing the growth of ... @ http://www.marketsandmarkets.com/Market-Reports/empty-capsules-market-218018190.html , Scope of Report ... as well as new entrants/smaller firms to gauge ...
Breaking Biology Technology:Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 4UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 3iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4
... (Nasdaq: BIOM ),(TSX: BRA) ("Biomira", the "Company") ... plan of arrangement under which the Company,will move ... to Oncothyreon Inc.,("Oncothyreon"). The approval came at a ... the plan of arrangement, which remains,subject to court ...
... Dec. 4 An independent panel of scientists,has ... Safe) status for its patented probiotic, GanedenBC30 (Bacillus ... research studies and,toxicology data, the panel concluded that ... food products. According to the FDA, self-affirmed GRAS,status ...
... Maxygen, Inc.,(Nasdaq: MAXY ), a biotechnology ... announced today the license of its proprietary,dengue virus ... of,the sanofi-aventis Group., Under the terms of ... portfolio of preclinical dengue antigens for development and,worldwide ...
Cached Biology Technology:Biomira Shareholders Approve Move to U.S. 2Biomira Shareholders Approve Move to U.S. 3Ganeden Biotech Obtains Self-Affirmed GRAS Status for Probiotic Ingredient, GanedenBC30 (Bacillus coagulans GBI-30, 6086) 2Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur 2Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur 3
(Date:12/19/2014)... LAS VEGAS , Dec. 18, 2014   ... platform built for the post-password and Internet of Things ... additional seed funding. The venture round was led by ... Pantera Capital, Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey ... the new funding to expand its team and bring ...
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
(Date:12/11/2014)... -- That blood pressure plays a role in human health has ... term for high blood pressure – was first described as ... that,s used in measuring blood pressure was invented in 1896. ... hypertension, its triggers and its effects. In fact, recent findings ... best ways to treat it. For example, a ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... may be useful in fighting malaria, researchers report in a ... the drug readily crosses into the red blood cells of ... at very low concentrations with no observed toxicity to the ... the National Academy of Sciences . The researchers found ...
... Stanford, CA -- The major difference between plant and ... energy into chemical energy. When light isn,t available, energy ... as it is in animal and some bacterial cells. ... the chloroplasts for photosynthesis and the mitochondria for sugar ...
... Humans are frequently blamed for deforestation and the destruction of ... around the world that have learned to manage and conserve ... Peruvian Amazon and the Tibetans of the Himalayas are two ... even in the face of rapid environmental changes. Over the ...
Cached Biology News:Modified bone drug kills malaria parasite in mice 2Amoeba may offer key clue to photosynthetic evolution 2Amoeba may offer key clue to photosynthetic evolution 3Indigenous peoples at forefront of climate change offer lessons on plant biodiversity 2Indigenous peoples at forefront of climate change offer lessons on plant biodiversity 3Indigenous peoples at forefront of climate change offer lessons on plant biodiversity 4
HSD17B3 Immunogen: HSD17B3 (NP_000188, 29 a.a. ~ 120 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rad51, N-terminal...
Phospho-mu-Opioid Receptor (Ser375) Antibody...
Rabbit polyclonal to WWOX8 ( Abpromise for all tested applications). entrezGeneID: 51741 SwissProtID: Q9NZC7-8...
Biology Products: